Last updated: July 21, 2023
Sponsor: Frank Behrendt
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hypochondriasis
Dystonias
Neurologic Disorders
Treatment
ExerG
Clinical Study ID
NCT05967078
2022-00559
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Primary end users:
- in-/ or outpatients of the Reha Rheinfelden
- Ability to speak and comprehend German and to understand the digitally transmittedtraining instructions
- Body height ≥ 160 cm or ≤ 200 cm according to hardware specifications
- Body weight ≤ 120 kg
- Able to execute the movements of the video game-based training (being able to transferfrom a sitting to a standing position and maintain the standing position withoutassistance for ≥ 2 minutes) Secondary end users:
- therapists (physiotherapist, occupational therapist, sport scientist, sport therapist,psychologists) working in the area of rehabilitation and prevention
- ≥ 21 years of age
- Bachelor's degree (scientists) or completed education as therapist
Exclusion
Exclusion Criteria: Primary end users
- Cognitive impairment as defined by a Mini Mental State Examination (MMSE) score of ≤ 18
- Severe visual, neurological, cardiorespiratory, psychiatric, or orthopedic impairmentswhich reduce the person's capability of following the instructions or to play the game
- Recently occurred epileptic seizures (in the past 3 months)
- Recent surgery/fractures/surgical interventions/joint replacement and malignancy (inthe past 3 months)
- Physical conditions in which a correct wearing of the Safety harness is not possibleor could cause pain or health problems (e.g. skin lesions, open wounds, knownpregnancy, severe osteoporosis)
- Joint contractures (e.g. shoulder, knee, hip) that could lead to limitations duringend-user evaluation of the ExerCube.
- Severe neurologic illness (e.g., strong epilepsy, advanced parkinson's syndrome,condition after severe stroke)
- Severe psychiatric illness (e.g., pronounced paranoid states, severe depression)
- Terminal illness (prognosis < 12 months)
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: ExerG
Phase:
Study Start date:
May 16, 2023
Estimated Completion Date:
October 31, 2023
Connect with a study center
Reha Rheinfelden
Rheinfelden, Aargau 4310
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.